These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 30427891)

  • 1. Modelling heterogeneity in host susceptibility to tuberculosis and its effect on public health interventions.
    Wangari IM; Trauer J; Stone L
    PLoS One; 2018; 13(11):e0206603. PubMed ID: 30427891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model for tuberculosis with exogenous reinfection.
    Feng Z; Castillo-Chavez C; Capurro AF
    Theor Popul Biol; 2000 May; 57(3):235-47. PubMed ID: 10828216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How host heterogeneity governs tuberculosis reinfection?
    Gomes MG; Aguas R; Lopes JS; Nunes MC; Rebelo C; Rodrigues P; Struchiner CJ
    Proc Biol Sci; 2012 Jun; 279(1737):2473-8. PubMed ID: 22357260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterogeneity in susceptibility to infection can explain high reinfection rates.
    Rodrigues P; Margheri A; Rebelo C; Gomes MG
    J Theor Biol; 2009 Jul; 259(2):280-90. PubMed ID: 19306886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of partial immunity on the prospects for tuberculosis control by post-exposure interventions.
    Gabriela M Gomes M; Rodrigues P; Hilker FM; Mantilla-Beniers NB; Muehlen M; Cristina Paulo A; Medley GF
    J Theor Biol; 2007 Oct; 248(4):608-17. PubMed ID: 17669435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach.
    Mandal S; Bhatia V; Sharma M; Mandal PP; Arinaminpathy N
    BMC Med; 2020 Jul; 18(1):163. PubMed ID: 32684164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Post-treatment effect of isoniazid preventive therapy on tuberculosis incidence in HIV-infected individuals on antiretroviral therapy.
    Sumner T; Houben RM; Rangaka MX; Maartens G; Boulle A; Wilkinson RJ; White RG
    AIDS; 2016 May; 30(8):1279-86. PubMed ID: 26950316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mobility and health disparities on the transmission dynamics of Tuberculosis.
    Moreno V; Espinoza B; Barley K; Paredes M; Bichara D; Mubayi A; Castillo-Chavez C
    Theor Biol Med Model; 2017 Jan; 14(1):3. PubMed ID: 28129769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reactivation or reinfection in adult tuberculosis: Is that the question?
    Cardona PJ
    Int J Mycobacteriol; 2016 Dec; 5(4):400-407. PubMed ID: 27931680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of isoniazid preventive therapy on incidence of tuberculosis among HIV-infected clients under pre-ART care, Jimma, Ethiopia: a retrospective cohort study.
    Assebe LF; Reda HL; Wubeneh AD; Lerebo WT; Lambert SM
    BMC Public Health; 2015 Apr; 15():346. PubMed ID: 25886730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis and HIV Coinfection.
    Bruchfeld J; Correia-Neves M; Källenius G
    Cold Spring Harb Perspect Med; 2015 Feb; 5(7):a017871. PubMed ID: 25722472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tuberculosis in Asia].
    Kekkaku; 2002 Oct; 77(10):693-7. PubMed ID: 12440145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The issue of tuberculosis in the elderly in Japan].
    Toyota M; Sasaki Y
    Kekkaku; 2010 Dec; 85(12):881-94. PubMed ID: 21404574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agents of change: The role of healthcare workers in the prevention of nosocomial and occupational tuberculosis.
    Nathavitharana RR; Bond P; Dramowski A; Kotze K; Lederer P; Oxley I; Peters JA; Rossouw C; van der Westhuizen HM; Willems B; Ting TX; von Delft A; von Delft D; Duarte R; Nardell E; Zumla A
    Presse Med; 2017 Mar; 46(2 Pt 2):e53-e62. PubMed ID: 28256382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction of a mathematical model for tuberculosis transmission in highly endemic regions of the Asia-Pacific.
    Trauer JM; Denholm JT; McBryde ES
    J Theor Biol; 2014 Oct; 358():74-84. PubMed ID: 24878110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous Reinfection as a Cause of Late Recurrent Tuberculosis in the United States.
    Interrante JD; Haddad MB; Kim L; Gandhi NR
    Ann Am Thorac Soc; 2015 Nov; 12(11):1619-26. PubMed ID: 26325356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The reinfection threshold promotes variability in tuberculosis epidemiology and vaccine efficacy.
    Gomes MG; Franco AO; Gomes MC; Medley GF
    Proc Biol Sci; 2004 Mar; 271(1539):617-23. PubMed ID: 15156920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs.
    Goletti D; Petrone L; Ippolito G; Niccoli L; Nannini C; Cantini F
    Expert Rev Anti Infect Ther; 2018 Jun; 16(6):501-512. PubMed ID: 29848120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.